+38 (095) 926-25-85
Trichocosmetics

The mysteries of grey hair

Hair colour

As beings with a highly developed visual perception and a need for social interaction, we rely heavily on appearance in contacts within our own species. It is therefore no surprise that phenotypic features, including the colour of our skin and hair, play a significant communicative role. Changes in pigmentation — from birth to puberty and then through adolescence, middle age and beyond — are perhaps one of the most significant signs of ageing. Loss of hair pigmentation occurs earlier and is more noticeable than the age-related changes in pigmentation seen in the epidermis. Although the skin contains the pigments haemoglobin and carotenoids, only melanins significantly affect the colour of skin and hair. In anthropology, hair colour is one of the key racial diagnostic anthroposcopic features. The observed racial and genetic differences in hair colour are related to protection against UV radiation. Nevertheless, the abundant growth and pigmentation of human scalp hair, which mattered for evolutionary selection, remain a mystery to this day [1]. Which shade appears depends on the form and distribution of the pigment — melanin. There are more than 50 different hair shades — from extremely fair to jet black. The whole range of colours is determined by two types of melanin: eumelanins and pheomelanins. Eumelanins are black and colour hair black and brown; pheomelanins are yellow or red and give hair a light shade.

Melanins are a class of mixed compounds with a high indole content, formed during melanogenesis – a phylogenetically ancient and complex biochemical pathway. This biochemical process takes place in unique lysosome-related organelles called melanosomes, which form in the cytoplasm of cells called melanocytes. The complex indoles of melanin are known to act as an important sink for sequestering potentially harmful materials within the long, heavily melanised hair fibres of the scalp, thereby limiting their access to, and potential damage of, the living scalp tissue with its rich blood supply. Eumelanins and pheomelanins provide natural photochemical protection for hair proteins [2].

The pigmentary unit of the hair follicle (HF) is highly susceptible to age-related changes, which are especially noticeable in people of European descent. Hair is at its lightest in early childhood; then, even before puberty, it gradually darkens and goes on darkening into adulthood until greying begins. The darkening of hair with age is largely due to the influence of hormones, including sex hormones and neuroendocrine factors. Hair colour also differs from one body site to another, which points to significant local variation in the hormonal stimulation of HFs. As a rule, the eyelashes are the darkest. Hair can fade in sunlight. After death, hair melanin slowly oxidises, which makes the hair lighter. Thus, the HF melanocyte is a kind of signal indicator of age-related processes and may point to the ageing of the hair [3]. 

Hair melanogenesis

The phenotypic difference between the melanocyte subpopulations of the HF and of the epidermis is extremely interesting, especially because both subpopulations arise from the same neural crest, and melanocyte stem cells of the adult HF can occupy vacant niches in the epidermis. The main reason why hair bulb melanocytes function differently from epidermal melanocytes appears to be the strict coupling of the former to the hair growth cycle, as opposed to the continuous, UV-sensitive melanogenesis of the latter. One of the surprises in the study of HF pigmentation was the presence of several melanocyte subpopulations in the HFs of the human scalp [4].

The most differentiated subpopulations of follicular melanocytes are located in the matrix of the hair bulb, above and around the upper part of the dermal papilla. These melanocytes transfer melanin directly into the keratinocytes of the hair cortex. An additional, small subpopulation of poorly differentiated melanocytes has been found in the HF, distributed in the most proximal and peripheral areas of the growing hair bulb. It has been suggested that they form a migratory population that helps maintain the number of functioning bulbar melanocytes and may have a role unrelated to pigmentation [4]. 

The transition from telogen to anagen is the only period of the hair growth cycle in which follicular melanocytes proliferate. Proliferating melanocytes are first detected during anagen II, followed by increased melanocyte mitosis in anagen III. Hair bulb melanocytes reach peak activity towards the end of anagen, the stage marked by maximal production of the hair fibre. The related melanocytes then differentiate, becoming larger and more dendritic in preparation for the active transfer of mature melanosomes to precortical keratinocytes in full anagen. 

During catagen regression of the HF, tyrosinase activity and expression levels fall sharply and follicular melanogenesis undergoes a physiological shutdown, which may indicate the production of inhibitors of melanocyte activity. This change in melanogenesis is seen before keratinocyte proliferation stops and is marked by retraction of the cells' dendrites, so that a brief ‘greying-like’ event occurs at the end of every hair growth cycle: keratinocyte proliferation continues on a limited scale for a short time, and so the last part of the hair to be produced contains no pigment. Thus, melanocytes remain functionally active only during anagen. In telogen they stay on the surface of the papilla in a shrunken state, without dendrites. A similar pigment incontinence is seen in greying, a further illustration of a certain similarity between the fate of hair bulb melanocytes in catagen and in greying [5][6].

Dermal papilla cells provide a biochemical environment that favours the production of large amounts of L-tyrosine from L-phenylalanine. The dermal papilla appears to have a redox environment that supports melanogenesis. Given that the production of reactive oxygen species (ROS) depends on melanogenesis, this is to be expected. The latter point matters for greying, since oxidative stress may play an important part in the formation of grey hair [5].

Endogenous and exogenous regulators of melanocyte life. Hair follicle melanocytes and their amelanotic precursors are highly specialised cells. Besides proliferation and apoptosis, their life cycle is regulated by a complex process of differentiation, by their ability to migrate to the intended site of activation, and by their specific synthetic activity – melanogenesis. In other words, the melanocyte is acted on by a number of enzymes, hormones, cytokines and growth factors that regulate the various processes of melanocyte activity; the most important of them are: adrenocorticotropic hormone; basic fibroblast growth factor; bone morphogenetic protein; calcitonin gene-related peptide; epidermal growth factor; endothelin; hepatocyte growth factor; interleukin; interferon; insulin-like growth factor; leukotriene; melanocortin; melanocyte-stimulating hormone; nerve growth factor; platelet-derived growth factor; prostaglandin; stem cell factor; transforming growth factor; tumour necrosis factor; Met - proto-oncogene (hepatocyte growth factor receptor); tyrosine kinase.

Changes in the expression or synthesis of any of these factors can disrupt downstream signalling and ultimately impair the production of pigment and its transfer to the target keratinocytes. Analysing the role of such a wide range of growth factors and their associated signalling cascades in hair follicle ageing, and studying their potential as therapeutic targets for anti-greying drugs, makes these factors themselves key targets of research into the greying process [7].

Natural greying

Greying (canities) is a physiological phenomenon and usually occurs alongside other signs of ageing of the body. The onset and progression of grey hair are closely tied to chronological ageing and eventually occur to some degree in everyone. The age at which greying begins is genetically controlled and inherited: on average, for example, Caucasians begin to go grey after thirty, Asians by forty, and Africans closer to fifty. It holds true that by the age of fifty, 50% of people have 50% grey hair. This prevalence of greying does not depend on sex or hair colour. In men, grey hair usually appears at the temples and sideburns. Women usually begin to go grey along the hairline. Gradually, the grey spreads to the crown, the sides and the back of the head [7]. 

Ageing HFs continually lose melanocytes. However, hair ageing does not always begin with greying, just as grey hair is not always a marker of old age. Greying can follow severe illness, endocrine disorders, or nervous and psychological shocks.

Although greying is regarded as a loss of pigment in the hair shaft, its cellular and molecular origins are not fully understood. There are 2 theories that explain hair greying. According to one, greying is associated with reduced tyrosinase activity and the resulting disruption of the interaction between melanocytes and trichocytes, slower migration of melanocytes into the hair bulb, impaired microcirculation, and the harmful effects on reserve melanocytes of UV radiation, chemicals, inflammation and other factors that promote the accumulation of defects in the cells' genetic machinery. The other theory explains hair greying by the accumulation of free radicals and the breakdown of the antioxidant system of the skin and HF [2].

The loss by the growing HF of melanocytes capable of actively producing and transferring pigment may be one of the protective strategies that allow skin and hair to cope with the various environmental and endogenous stresses that constantly accompany a person throughout life. Of these possible stresses, oxidative stress is the most common.

There is evidence of reciprocal activity between melanocytes and keratinocytes, which can be obtained clinically by examining the hair fibre: a grey hair is usually coarser, more wiry and less manageable than its pigmented counterpart. Here too, the absence of melanin points to a change in the chemical and physical properties of the hair after pigmentation. In addition, grey hair is often hard to style and more resistant to artificial colouring. These changes have a significant impact on the cosmetics industry. Based on the above, greying hair follicles are likely to reprogramme their matrix keratinocytes to produce more medullary rather than precortical keratinocytes. Some age-related changes may partly spare the ‘older’ white hairs. Grey hair is known to grow 4 times faster than pigmented hair, the average diameter of recently greyed fibres is significantly larger than that of pigmented ones, grey hair is less affected by androgenetic alopecia (AGA), and, unlike pigmented scalp hair, it is resistant to autoimmune processes [8].

A hypothetical scenario for ageing of the HF pigmentary unit

Melanocytic oxidative stress within the HF itself runs quite high, since melanin is produced continuously throughout anagen for as long as the melanocyte is functioning. This involves enzymatic processes such as peroxidase oxidation. It is therefore not surprising that the HF melanocyte is well adapted to protect itself against oxidative stress. However, with ageing or additional oxidative stress (for example, UV exposure, inflammatory stress, direct exposure to exogenous oxygen radicals and similar substances), and also under psycho-emotional stress, melanocytes lose their balance and develop oxidative damage that ultimately leads to their apoptosis [6][7]. On the one hand, apoptosis intensifies and functioning melanocytes are lost from the pigmentary unit; on the other, melanocyte stem cells in the niche are activated. The resulting increase in turnover shrinks the melanocyte stem cell pool. 

This process depends on the presence of a flexible reservoir of ‘stem’ melanocytes located in the permanent part of the HF [9]. As mentioned above, the HF pigmentary unit functions at its peak in late adolescence and early adulthood, when terminal hair growth is optimal and hair colour has settled, that is, in the period of full response to post-pubertal hormonal stimuli. This age group corresponds to a follicular melanin unit that is several hair growth cycles old. Given that the average hair growth cycle lasts 3.5 years, individual HFs in Caucasians will see fewer than ten repeated dispersals of melanocytes from the presumed reservoir over an average grey-free lifespan of 35-40 years. Thus, the HF melanocyte is a kind of signal indicator of age-related processes and may point to the ageing of the hair. Stress is thought, on the one hand, to cause a premature decline of the HF pigmentary system and, on the other, to protect DNA from oncogenic damage [2].


Diagnosis and treatment at the Institute

Get a consultation

Premature greying of hair

The rate at which a person goes grey is genetically determined and may vary between body sites and even within a single site. This heterogeneity may reflect differences in internal ‘melanogenetic clocks’, or, more precisely, a shortage or absence of favourable microenvironments. Thus, pigment loss in the epidermis is gradual, whereas age-related loss of hair colour can be more rapid. Heredity is probably the dominant factor, and most cases of greying are inherited in an autosomal dominant pattern. This could explain why many members of the same family may all show early or unusually late greying. The size of melanocyte reservoirs may differ between individuals and between tissues, which may reflect different rates of ‘dispersal’ from the neural crest as melanocyte precursors migrate during embryogenesis. Several congenital conditions are characterised by abnormal migration of melanocyte precursors along stereotyped routes, piebaldism being one example [10]. Greying is called premature when it occurs before the age of 20 in white people, before 25 in Asians and before 30 in Africans. And although premature greying, presumably inherited in an autosomal dominant pattern (familial premature greying), more often appears without any underlying disease, it has been associated with a group of related autoimmune disorders seen alongside vitiligo, pernicious anaemia and autoimmune thyroid disease, as well as with several rare premature ageing syndromes, such as Hutchinson-Gilford syndrome and Werner syndrome. In Curschmann-Steinert myotonic dystrophy, greying may precede myotonia and muscle atrophy. In Böök syndrome, which is inherited in an autosomal dominant pattern, premature greying is accompanied by premolar hypodontia and hyperhidrosis of the palms and soles [11].

The term canities subita is used to describe a sudden onset of greying, or greying ‘overnight’. Today this phenomenon is interpreted as an acute episode of alopecia areata (AA), in which the rapid greying is caused by the selective shedding of pigmented hairs in this presumably immune-mediated disorder. This observation has led some experts to suggest that the autoimmune target in AA may be linked to the melanin pigment system. The Marie Antoinette (in women)  and Thomas More (in men) phenomena have been described. In this type of AA, an autoimmune reaction to acute stress is suspected, targeting melanocytes and melanogenesis-related proteins in the setting of abnormal HLA class I expression on the anagen hair bulb [12]

Greying caused by nutritional deficiencies. Inborn errors of metabolism with hair hypopigmentation have been described: phenylketonuria, homocystinuria, Hartnup disease and methionine malabsorption syndrome. Nutrient deficiencies known to affect hair pigmentation include protein-energy malnutrition and deficiency of vitamin B12, essential fatty acids, zinc, copper or selenium [13][14].

Greying may also be drug-induced. Some systemic drugs can change hair colour by interfering directly with melanin synthesis pathways: for example, chloroquine and hydroxychloroquine inhibit pheomelanin synthesis and so affect only fair and red hair. After 3-4 months of treatment the hair turns silvery or white, usually first at the temples and in the eyebrows. These changes are reversible. Etretinate, fluorobutyrophenone and triparanol disrupt keratinisation and cause hypopigmentation and thinning of the hair. The colour change may be due to impaired incorporation of melanosomes into the keratinocytes of the hair shaft cortex, or to an optical effect resulting from a disrupted substructure of the hair fibre. Drug-induced loss of hair pigment has also been reported for bleomycin, etretinate, fluorobutyrophenone, haloperidol, mephenesin, tamoxifen, triparanol, valproate and verapamil, but the mechanism by which these drugs affect pigmentation is unknown [15]

There are reports linking  premature greying and smoking. Mosley and Gibbs were the first to draw attention to the role of tobacco smoking in greying and hair loss in men. There are not yet enough statistical data to claim that these factors affect women's hair just as negatively. The likely mechanisms of hair damage in such cases are multifactorial and involve the effect of tobacco smoke on the microvasculature of the hair papillae, genotoxic effects on hair follicle DNA, rising concentrations of pro-inflammatory cytokines, the development of perifollicular fibrosis and micro-inflammation, and also the hydroxylation of oestradiol, which creates a relative deficiency of active oestrogens [16]

Cases of spontaneous hair repigmentation. Apart from correcting nutrient deficiencies, stopping a drug presumed to be the cause, and giving up smoking, there are as yet no other natural ways to preserve the pigment of dark hair or to reverse the appearance of grey hair. Reports of spontaneous repigmentation of grey hair in the medical literature are extremely rare, although the phenomenon itself may be more common than is generally thought. Moreover, melanocytes taken from grey and white hair follicles can produce pigment in vitro [2][17][18].

Hair repigmentation has been reported in the following cases: after inflammation, after radiotherapy, after photosensitive dermatitis, in association with adult coeliac disease, after erosive candidiasis of the scalp, during treatment of Parkinson's disease with carbidopa and bromocriptine, after chemotherapy, in connection with etretinate treatment, after ciclosporin A therapy, in porphyria cutanea tarda, during treatment of disseminated granuloma annulare with defibrotide, in patients with hepatitis C treated with interferon and ribavirin, after treatment with thyroid hormones, and after systemic corticosteroids for bullous pemphigoid. The most extreme cases of pigment recovery are seen in  AA. Notably, AA usually does not affect white or grey hair, and when hair regrows, unpigmented hair shafts appear first and are repigmented later. Reports of grey hair repigmentation accompanying Addison's disease have also been linked to a mechanism similar to that of AA or vitiligo, given the known association between these diseases. An alternative explanation may be the effect of raised levels of melanocyte-stimulating hormone, which is also involved in the darkening of skin and hair in Nelson syndrome and ectopic ACTH hypersecretion syndrome. Since stimulated pigment formation can also affect the hair, marked darkening of the hair may suggest the possible presence of such diseases [2][17][18].

Current therapeutic concepts for reversing involutional pigment loss

Research into hair ageing focuses on the aesthetic problem of ageing and its control, and on the biological side of ageing in terms of microscopic, biochemical and molecular changes. With life expectancy rising, the wish to look young is stronger than ever. The cosmetics industry is responding actively to this wish, offering active products designed to meet this new consumer demand. As there is at present no other way to reverse the appearance of grey hair, hair dyes remain the main means of hiding the loss of colour. Nevertheless, new discoveries in the biology of hair follicle ageing may lead to new strategies for preventing and reversing greying. Among these discoveries, close attention is being paid to the ‘free radical theory’ and to in-depth study of the maximum potential of hair follicle melanocyte populations, their protection and their activation.

The quantity and quality of hair are closely linked to a person's nutrition. A lack of protein and calories in the diet, and deficiencies of certain essential amino acids, trace elements and/or vitamins, lead to disorders of hair growth and pigmentation. The effect of nutrition on hair growth has been assessed through observations of rare inborn errors of metabolism and nutritional deficiencies, and in studies of dietary supplements. Darkening of the hair has been reported after high doses of para-aminobenzoic acid (PABA) [19][20]: in Sieve's study, 460 grey-haired patients received 100 mg of PABA three times a day, and 82% responded. The darkening became noticeable in the 2nd-4th month of treatment. Within 2-4 weeks of stopping therapy, the hair turned grey again. The mechanism of action remains unclear. The main drawback of the method is its gastrointestinal side effects. For this reason, PABA is added to oral supplements for hair growth and colour in smaller doses. Proven efficacy for hair growth and pigmentation has been shown by the CYP complex, a combination of L-cystine, medicinal yeast and PABA [20][21][22].

Darkening of the hair has also been observed during treatment of androgenetic alopecia with minoxidil – a topical agent that promotes hair growth. The mechanism probably involves prolonging anagen and enlarging the follicle, stimulating normal melanogenesis [23].

Since reactive oxygen species have been implicated in hair follicle melanocyte apoptosis and DNA damage, and L-methionine can prevent Met oxidation of tyrosinase in vitro, it will be interesting to find out whether L-methionine could help to fight greying or to reverse it [24].

There is also growing interest in the routes by which active compounds that act on hair are delivered. Current research focuses on selective liposomal delivery of melanins, genes and proteins to hair follicles for therapeutic and cosmetic modification of hair.

Another direction in the search for new treatments for pigment loss is tissue engineering of hair follicle cells with stem cell properties [25].

Summary

Greying, as a visible sign of ageing, has drawn the attention of scientists since time immemorial. Yet only recently have answers begun to emerge to questions about the biology of hair pigmentation and greying. Prominent among them are the ageing hair follicle, the theory that ‘free radicals’ are involved in greying[2], and in-depth study of the maximum potential of hair follicle melanocyte populations. Precise identification and effective delivery of the appropriate protective and/or triggering mechanisms, which would respectively protect melanocytes from oxidative stress or stimulate the activation of dormant stem cells, could make the prevention and reversal of greying a reality.

References

  1.  Злотогорский А., Шапиро Д. [и др.]. Трихология / под ред. А. Литуса; пер. с англ. Ю. Овчаренко. – К.: Рудь, 2013. – 160 с., ил.
  2. Ralph M. Trüeb. Desmond J. Tobin (Eds.) Aging Hair // Springer, 2010. – 270 p.
  3.  Fitzpatrick TB, Brunet P, Kukita A (1958) The nature of hair pigment. In: Montagna W, Ellis RA (eds) The biology of hair growth. Academic Press, New York, pp 255–303
  4. Tobin DJ, Bystryn J-C (1996) Different populations of melanocytes are present in hair follicles and epidermis. Pigment Cell Res 9:304–310
  5. Tobin DJ (2008) Biology of hair follicle pigmentation. In: Blume-Peytavi U, Tosti A, Whiting D, Trueb R (eds) Hair growth and disorders. Springer, Berlin, pp 51–74
  6. Tobin DJ (2003) The ageing hair follicle pigmentary unit. In:Van Neste D (ed) Hair science and technology. Skinterface srl, Tournai, Belgium, pp 155–168
  7. Tobin DJ, Paus R (2001) Graying: gerontobiology of the hair follicle pigmentary unit. Exp gerontol 36:29–54
  8. Van Neste D, Tobin DJ (2004) Hair cycle and dynamic interactions and changes associated with aging. Micron 35:193–200
  9.  Nishimura EK, Jordan SA, Oshima H et al (2002) Dominant role of the niche in melanocyte stem-cell fate determination. Nature 416:854–860
  10. Spritz RA (1997) Piebaldism, Waardenburg syndrome, and related disorders of melanocyte development. Semin Cutan Med Surg 16(1):15–23
  11. Book JA (1950) Clinical and genetic studies in hypodontia. Premolar aplasia, hyperhidrosis and canities premature: a new hereditary syndrome in man. Am J Human Genet 2: 240–263
  12. Paus R, Slominski A, Czarnetzki BM (1994) Is alopecia areata an autoimmune-response against melanogenesisrelated proteins, exposed by abnormal MHC class I expression in the anagen hair bulb? Yale J Biol Med 66: 541–554
  13. Zaun H, Perret (1990) Internal diseases affecting hair growth. In: Orfanos CE, Happle R (eds) Hair and hair diseases. Springer, Berlin, p 587 ff
  14. Бобейко Ю.С. Количественные и качественные характеристики аминокислотного пула у больных очаговой алопецией // Медицина сегодня и завтра. – 2003. – № 1. – С. 64–67.
  15. Trueb RM (2006) Pharmacologic interventions in aging hair. Clin Interv Aging 1:121–129
  16. Mosley JG, Gibbs CC (1996) Premature gray hair and hair loss among smokers: a new opportunity for health education? BMJ 313:1616
  17. Pattier P (2001) Spontaneous repigmentation of white hair. Ann Dermatol Venereol 128:1082–1083. French
  18. Trüeb R. M. Hormone und Haarwachstum // Hautarzt. – 2010. – 61: 487–95.
  19.  Zarafonetis C (1950) Darkening of gray hair during paraaminobenzoic acid therapy. J Invest Dermatol 15:399–49160.
  20.  Sieve B (1941) Darkening of gray hair following para-aminobenzoic acid. Science 94:257–258
  21. Овчаренко Ю.С. Диффузная алопеция: диагностика и лечение//Дерматологія та венерологія. - 2011, №3(53). – с.78-84.
  22.  Trueb R.M. et al., The Value of Dietary Supplements: Results of a Double-Blind Placebo-Controlled Study with Oral Combination of Cystine, Yeast and Pantothenic Acid. – 2005
  23. Trueb R. M. Aging of hair // J Cosmet Dermatol. – 2005. – 4: 60–72.
  24. Wood JM, Decker H, Hartmann H et al (2009) Senile hair graying: H2O2-mediated oxidative stress affects human hair color by blunting methionine sulfoxide repair. FASEB J 23:2065–2075
  25. Yonetani S, Moriyama M, Nishigori C et al (2008) In vitro expansion of immature melanoblasts and their ability to repopulate melanocyte stem cells in the hair follicle. J Invest Dermatol 128:408–420